Clinical Trials Directory

Trials / Unknown

UnknownNCT04082390

Effects of the GOLO for Life System Diet With and Without GOLO Release Supplement on Glycemic Control and Insulin Resistance

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effects of the GOLO for Life System Diet With and Without GOLO Release Supplement on Glycemic Control and Insulin Resistance in Overweight and Obese Subjects With Type 2 Diabetes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Golo · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This randomized, double-blind placebo-controlled study is intended to observe the short-term effects of the GFL System Diet with Release supplement versus GFL System Diet with placebo on glycemic metabolism and insulin resistance in patients with Type 2 DM.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRELEASEDietary supplement
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2019-10-01
Primary completion
2020-01-30
Completion
2020-01-31
First posted
2019-09-09
Last updated
2019-09-09

Source: ClinicalTrials.gov record NCT04082390. Inclusion in this directory is not an endorsement.

Effects of the GOLO for Life System Diet With and Without GOLO Release Supplement on Glycemic Control and Insulin Resist (NCT04082390) · Clinical Trials Directory